Bain Capital Life Sciences Investors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-701,402	Closed	-$11.2M	–	35
2022 Q4	$11.2M	Buy	701,402 +90,879	+15%	+$1.45M	1.25%	22
2022 Q3	$9.99M	Buy	610,523 +10,000	+2%	+$164K	1.19%	21
2022 Q2	$8.46M	Buy	+600,523	New	+$8.46M	0.99%	21